SOLITARY pulmonary nodules have caused considerable concern ever since the advent of roentgenography made their detection possible during life. This concern has been heightened in recent years by the ...

Examination of the influence that lymphatic and venous involvement gives consequence of stage I non small-cell lung cancer in new TNM classification. Background: The multidisciplinary lung cancer ...

Patients were satisfied with receiving their lung cancer screening (LCS) pulmonary nodule results via letter and considered the amount of information provided in the letter appropriate. Study Design: ...

A solitary lung nodule (SLN) is seen in 1 in 500 chest radiographs. Benign causes include infectious granulomas and hamartomas, and less commonly, rheumatoid nodules, intrapulmonary lymph nodes and ...

Induction cetuximab (C) followed by C, paclitaxel (P), carboplatin (CP) and concurrent radiation (RT) for locoregionally advanced squamous cell carcinoma of the head and neck (SCCHN) The presence of a ...

Please provide your email address to receive an email when new articles are posted on . Pulmonary nodule stability was frequently observed on veterans’ follow-up CT scans. Other findings on follow-up ...

Tempus AI, Inc. TEM recently announced a collaboration with Median Technologies to integrate Median’s proprietary eyonis LCS solution into the Tempus Pixel platform. The integration is expected to ...

Dr. Margo A. Peyton (Medicine): A 43-year-old man was evaluated in the multidisciplinary Pulmonary Nodule Clinic of this hospital because of an incidentally found pulmonary nodule. One month before ...

The proposed CNN-based system demonstrates the feasibility and robustness of deep learning for automatic lung nodule detection and classification. Despite strong results, the study acknowledges ...

Background and objectives Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and effective treatment.

PARIS & SAN JOSE, CALIF.--(BUSINESS WIRE)--Broncus Medical, Inc., developer of diagnostic and therapeutic technologies for lung disease, today announced new data unveiled at the European Respiratory ...